National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dendritic cell-CEA peptide vaccine
A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:CEA peptide-pulsed DC vaccine
CEA peptide-pulsed dendritic cell vaccine
Dendritic cell-carcinoembryonic antigen peptide vaccine



Previous:Demerol, demineralized bone matrix, DEMSER, Dendrid, dendritic cell-autologous lung tumor vaccine
Next:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine, dendritic cell-MART-1 peptide vaccine, denileukin diftitox, denosumab, Depade

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov